<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1709">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04347928</url>
  </required_header>
  <id_info>
    <org_study_id>2020_32</org_study_id>
    <secondary_id>2020-A00957-32</secondary_id>
    <nct_id>NCT04347928</nct_id>
  </id_info>
  <brief_title>Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19</brief_title>
  <acronym>PHYSIO-COVID</acronym>
  <official_title>Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present context, it seems necessary to try to describe as precisely as possible the&#xD;
      physiological alterations due to COVID-19. From these observations, therapeutic proposals&#xD;
      adapted to this new disease may then be developed, particularly in the symptomatic management&#xD;
      of the critically ill patient. It therefore seems essential to rigorously study these&#xD;
      modifications, as they have been studied in the past for ARDS.&#xD;
&#xD;
      The aim of this non-interventional study is to describe precisely the respiratory and&#xD;
      hemodynamic changes induced by COVID-19 in mechanically ventilated patients&#xD;
&#xD;
      .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 20, 2020</start_date>
  <completion_date type="Actual">November 6, 2020</completion_date>
  <primary_completion_date type="Actual">November 6, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>intrapulmonary shunt ratio</measure>
    <time_frame>during ICU stay, in the first 72 hours of mechanical ventilation initiation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of respiratory variables</measure>
    <time_frame>during ICU stay, in the first 72 hours of mechanical ventilation initiation</time_frame>
    <description>Evaluation of PaO2 variation between in a high level of PEEP (15cmH2O) and a low level of PEEP (5cmH2O)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of respiratory variables</measure>
    <time_frame>during ICU stay, in the first 72 hours of mechanical ventilation initiation</time_frame>
    <description>Evaluation of PaCO2 variation between in a high level of PEEP (15cmH2O) and a low level of PEEP (5cmH2O)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of hemodynamic stability variables</measure>
    <time_frame>during ICU stay, in the first 72 hours of mechanical ventilation initiation</time_frame>
    <description>Evaluation of cardiac output variation between a high level of PEEP (15cmH2O) and a low level of PEEP (5cmH2O)</description>
  </secondary_outcome>
  <enrollment type="Actual">15</enrollment>
  <condition>COVID-19</condition>
  <condition>ARDS</condition>
  <condition>Sars-CoV2</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patient hospitalized in ICU mechanically ventilated for less than 72 hours&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hospitalized in intensive care for a SARS-CoV2 infection&#xD;
&#xD;
          -  requiring invasive ventilation,&#xD;
&#xD;
          -  intubated for less than 72 hours with PaO2/FiO2 ratio &lt; 200 mmHg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient mechanically ventilated for 72 hours or more&#xD;
&#xD;
          -  Patient with documented respiratory co-infection&#xD;
&#xD;
          -  Patient with a contraindication to pulmonary artery catheter insertion: High risk of&#xD;
             bleeding, pre-existing high degree of atrioventricular heart block , Pace Maker&#xD;
&#xD;
          -  Patient with spontaneous ventilation&#xD;
&#xD;
          -  Patient with severe ARDS with static compliance of the respiratory system &lt; 20&#xD;
             mL/cmH2O&#xD;
&#xD;
          -  Patient with severe ARDS with indication of prone positioning at inclusion.&#xD;
&#xD;
          -  Patient with a cardiac condition that renders the measurement of pulmonary artery&#xD;
             occlusion pressure uninterpretable as a surrogate for left ventricle end diastolic&#xD;
             pressure (severe mitral insufficiency, severe mitral stricture, severe aortic&#xD;
             insufficiency).&#xD;
&#xD;
          -  Patient with intracardiac shunt&#xD;
&#xD;
          -  Patient with ECMO&#xD;
&#xD;
          -  Minors and pregnant women.&#xD;
&#xD;
          -  Person not affiliated to or not benefiting from a social security scheme.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thibault Duburcq, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Roger Salengro, CHU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>November 16, 2020</last_update_submitted>
  <last_update_submitted_qc>November 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

